Bukhari HA, Afzal M, Al-Abbasi FA, et al
The Company's novel class of brain-penetrant NLRP3 inhibitors, which have demonstrated high potency and a novel binding site, are progressing toward IND submission, anticipated in the second half of 2025
Overall, feedback suggests there is potential value in some instances, but both patients and providers must remain cautious and well-informed when considering this treatment
J., & Santos, H
Folate Folate is a B vitamin that Research suggests folate deficiency may contribute to low platelet count, although its unlikely to be the only factor
Additionally, GLP-1 receptor activation affects gastrointestinal motility throughout the entire digestive tract, potentially leading to constipation in some patients or altered bowel habits